What an inspiring evening of innovation and collaboration! Last Thursday, Eagle IP was honored to once again host the American Intellectual Property Law Association (AIPLA) Women in IP Global Networking Event in Hong Kong, joining forces with hundreds of remarkable women across 40+ global cities.

In the spirit of this year’s theme “Innovation and Collaboration,” we gathered fellow female leaders, innovators, entrepreneurs and IP practitioners to share their amazing career journeys and lessons learnt along the way. We started off the evening with Jennifer Che and Pauli Wong, sharing their paths from scientists that transitioned into an IP career, and what it means to them now to support scientists as IP professionals. We were also privileged to have Dr. Cathy Jim, of RHT Industries Limited, share with us her inspiring journey as a Chemist and Entrepreneur. Cathy recounted how she and her team overcame many difficulties along their path to providing a better solution to real world air quality problems through science. Her one piece of advice and guiding principle? Resilience. At 8PM HKT, we promptly dialed into a joint video call to say hello to hundreds of women at 40+ participating cities around the world holding their own simultaneous events.

To all who joined us: thank you for your lively participation and sharing. Together, we’re not just shaping the future of innovation—we’re redefining what it means to lead. Here’s to many more years of collaboration, growth, and breaking barriers!

Our Past Events

Recommended Insights

China’s Newest Examination Guidelines: Post-Filing Supplemental Data for Compounds (Part I)

28 April 2021
Post-filing data in China has been a constant issue for many patent practitioners around the world. Examiners seem to require it often, and yet the rules regarding when it is acceptable have seemed much stricter than other jurisdictions worldwide. In fact, we tried to summarize the latest state of the law in an earlier blog […]

Inventive Step for an Enantiomer over a Racemate: “L-ornidazole” Patent Invalidation Case

27 November 2023
Each year, China’s Supreme People’s Court (SPC) issues its annual “Judgment Digests”, which includes a list of “48 typical cases” highlighting representative SPC decisions in the previous year. The Judgment Digests help us understand more about the SPC’s judicial ideology, trial concepts, and adjudication methods in dealing with difficult and sophisticated legal issues as well […]

Breaking: China Released New Implementation Measures for the New Patent Linkage System

14 July 2021
On July 4, 2021, China’s National Medical Products Administration (NMPA) and the China National Intellectual Property Administration (CNIPA) released details on the new implementation measures for early dispute resolution mechanisms for drug patents (“Patent Linkage”), effective July 4, 2021. Below is a summary highlighting key provisions and changes from the draft measures. Creation of an […]

China’s Supreme People’s Court (SPC) Hands Down First Patent Linkage Appeal Decision

21 September 2022
China has been implementing a plethora of new laws and measures that are particularly favorable to drug companies, such as patent term extension and patent linkage.  Details of the new implementation measures for patent linkage (technically “early dispute resolution mechanisms for drug patents”) came into effect on July 4, 2021. At around the same time, […]
Top crossarrow-right